Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments

Abbott Laboratories is an American multinational medical devices and health care company. It sells medical devices, diagnostics, branded generic medicines and nutritional products.

 
 
 
 
 

Hold off investments: company postponing future planned investment/development/marketing while continuing substantive business

Stay Pausing Investments
USA
Pharma & Healthcare

Global 500, is an annual ranking of the top 500 corporations worldwide

Global 500

Top 100 largest companies in Russia by revenue

Top 100
Revenue(RF), mln.USD
726
Assets(RF), mln.USD
1129
Capital(RF), mln.USD
529
Glob.Revenue, mln.USD
43653
Offices
2
Plants
3
Staff(RF), 2021
721
Taxes(RF), mln.USD
120

Pharmaceutical production.

The Company Statement
April 29, 2022

The company suspends non-essential business activity in the country, including all new investments, business development and advertising. So far, the only product (treatment of diabetes) left on the Russian market is the American Abbott.

Open the Statement
Statements Archive
September 21, 2023Problems began with the import of products for the treatment of diabetes
April 05, 2023Letter sent by B4Ukraine to the company (no response provided)
Demand to Leave Russia:Petition text has been copied to the clipboard.
Share the Company Status:
All company names used on this web page are for identification purposes only. All trademarks and registered trademarks are the property of their respective owners.
Company statements and statistical data are collected from open sources and official registers according to the methodology of the KSE Institute.
Scanner